EA200800707A1 - Фармацевтическая композиция, содержащая экстракт из растений рода solidago - Google Patents

Фармацевтическая композиция, содержащая экстракт из растений рода solidago

Info

Publication number
EA200800707A1
EA200800707A1 EA200800707A EA200800707A EA200800707A1 EA 200800707 A1 EA200800707 A1 EA 200800707A1 EA 200800707 A EA200800707 A EA 200800707A EA 200800707 A EA200800707 A EA 200800707A EA 200800707 A1 EA200800707 A1 EA 200800707A1
Authority
EA
Eurasian Patent Office
Prior art keywords
plants
pharmaceutical composition
composition containing
containing extract
extract
Prior art date
Application number
EA200800707A
Other languages
English (en)
Inventor
Петер Литерати Надь
Кальман Тори
Аттила Колонич
Агнеш Кэри
Лайош Ласло
Ласло Йаслитш
Агнеш Байза
Шандор Бернат
Ласло Виг
Тибор Боднар
Янош Эгри
Original Assignee
Эльшо Мадьяр Биодрог Кутато Эш Фейлесто Кфт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эльшо Мадьяр Биодрог Кутато Эш Фейлесто Кфт filed Critical Эльшо Мадьяр Биодрог Кутато Эш Фейлесто Кфт
Publication of EA200800707A1 publication Critical patent/EA200800707A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)

Abstract

Экстракт части растений видов Solidago, где указанная часть является надземной, или сухой остаток, остающийся после удаления растворителя из экстракта, в качестве активного ингредиента применяют для усиления митохондриального генеза, таким образом, укрепляя организм млекопитающего, или для предотвращения или лечения заболеваний, вызванных повреждением митохондрий и/или пониженной функцией фермента конститутивной синтазы оксида азота.
EA200800707A 2005-09-01 2006-08-30 Фармацевтическая композиция, содержащая экстракт из растений рода solidago EA200800707A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0500814A HUP0500814A2 (en) 2005-09-01 2005-09-01 Pharmaceutical composition containing solidago sp. extract
PCT/HU2006/000070 WO2007026184A2 (en) 2005-09-01 2006-08-30 A pharmaceutical composition containing an extract of a solidago species

Publications (1)

Publication Number Publication Date
EA200800707A1 true EA200800707A1 (ru) 2008-08-29

Family

ID=89986243

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800707A EA200800707A1 (ru) 2005-09-01 2006-08-30 Фармацевтическая композиция, содержащая экстракт из растений рода solidago

Country Status (7)

Country Link
US (1) US20090214677A1 (ru)
EP (1) EP1928482A2 (ru)
JP (1) JP2009507010A (ru)
CA (1) CA2620873A1 (ru)
EA (1) EA200800707A1 (ru)
HU (1) HUP0500814A2 (ru)
WO (1) WO2007026184A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3044226B1 (fr) * 2015-11-26 2017-12-08 Chanel Parfums Beaute Extrait alcoolique de parties aeriennes de solidago virgaurea subsp. alpestris, son procede d'obtention, et composition cosmetique ou dermatologique le contenant
CN114403101B (zh) * 2022-01-25 2023-06-09 江苏大学 一种利用中华剑角蝗防治入侵杂草加拿大一枝黄花的方法
WO2023212353A1 (en) * 2022-04-29 2023-11-02 Emory University Viral entry inhibitors derived from botanicals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376372A (en) * 1989-07-11 1994-12-27 Steigerwald Arzneimittelwerk Gmbh Analgesic and inflammation-reducing medicament

Also Published As

Publication number Publication date
JP2009507010A (ja) 2009-02-19
US20090214677A1 (en) 2009-08-27
CA2620873A1 (en) 2007-03-08
HUP0500814A2 (en) 2008-02-28
EP1928482A2 (en) 2008-06-11
WO2007026184A2 (en) 2007-03-08
WO2007026184A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
Saleem et al. Hepatoprotective effect of Chenopodium murale in mice
BRPI0608051A2 (pt) método de extração de resìduos de pesticidas e kit de extração
ES2421604T3 (es) Hidrocoloide protector para ingredientes activos
WO2006075330A3 (en) Methods and pharmaceutical compositions useful for treating psoriasis
NO20061326L (no) Anvendelse av ekstrakter fra knottre
JP2006282617A5 (ru)
AR089777A1 (es) Solucion amortiguadora para desparafinado que contiene un solvente organico soluble en agua y metodos para su uso
EA200800707A1 (ru) Фармацевтическая композиция, содержащая экстракт из растений рода solidago
PA8661701A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
NO20080515L (no) Aktiv fraksjon fra et polart losningsmiddelekstrakt fra lates fra euphoribiaceae-plantene
WO2007024510A3 (en) Medicinal herbal composition for treating infection
AR046729A1 (es) Concentrado de tienil-sulfonamidas para suspender en aceites
ATE472316T1 (de) Haarbehandlungszusammensetzungen
Kamboj et al. Phytochemical Screening, In-vitro Evaluation of Antioxidant and Free Radical Scavenging Activity of Leaves, Stems and Roots of Xanthium strumarium L.,(Compositae).
BRPI0518478A2 (pt) composiÇço de verniz para uso cosmÉtico ou farmacÊutico e utilizaÇço de solvente de origem vegetal
Roy et al. Evaluation of anti-ulcer effects of ethanolic extract of Delonix regia flower
BRPI0415945A (pt) uso de partes de plantas de pêra espinhosa (opuntia) e/ou extratos da mesma para o tratamento de depressões
BR112013019251A2 (pt) processo para a preparação de um extrato de ervas
Salleh et al. Preliminary investigations of antioxidant, antityrosinase, acetylcholinesterase and anti-inflammatory activities of Actinodaphne species
EA200900914A1 (ru) Способ, применение и агент для защиты растения от питиум и ризоктония
RU2007130551A (ru) Пероральные композиции для предотвращения повреждения уф лучами
Swathi et al. Evaluation Of Hepatoprotective Activity Of Ethanolic Extract Of Adiantum Lunulatum Burm. F
ATE427113T1 (de) Zusammensetzung zur behandlung von diabetischer periodontitis
Ambarwati et al. Elastase and COVID-19 relationship, and potential natural resource as elastase inhibitors: A comprehensive review
AR072319A1 (es) Composicion de hierbas por via oral para el tratamiento de la candidiasis oral, proceso, uso